Baker Tilly Wealth Management, LLC Catalent, Inc. Transaction History

Baker Tilly Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	BUY	$87.2 - $114.05 $167,336 - $218,861	1,919 New	1,919 $206,000
Q1 2022 Apr 27, 2022	SELL	$94.19 - $124.49 $169,447 - $223,957	-1,799 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$119.57 - $139.07 $31,327 - $36,436	262 Added 17.05%	1,799 $230,000
Q3 2021 Nov 02, 2021	BUY	$109.17 - $142.35 $167,794 - $218,791	1,537 New	1,537 $205,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Baker Tilly Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Baker Tilly Wealth Management, LLC with notifications on news.